JOHN RIVERA: Open Payments
NPI 1720044811 · MILLDALE, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,846 in 102 payments from 13 companies in 2025. Trend: 2023 $1,785 · 2024 $1,622 · 2025 $1,846
Food & beverage: $1,846
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $377 |
| AstraZeneca Pharmaceuticals LP | 14 | $336 |
| PFIZER INC. | 15 | $242 |
| GlaxoSmithKline, LLC. | 12 | $204 |
| Novo Nordisk Inc | 9 | $183 |
| Amgen Inc. | 7 | $138 |
| Lilly USA, LLC | 5 | $113 |
| Merck Sharp & Dohme LLC | 4 | $95 |
| Exact Sciences Corporation | 3 | $83 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
Products named: VRAYLAR, BREZTRI, TRELEGY ELLIPTA, NURTEC ODT, AIRSUPRA, QULIPTA, Wegovy, PREVNAR 20.
Industry payments across CT — which companies pay providers there.
